{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T02:08:06Z","timestamp":1706062086626},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T00:00:00Z","timestamp":1110931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p><jats:italic>Hintergrund:<\/jats:italic>Das Erysipel ist eine auf die Kutis und Subkutis beschr\u00e4nkte meist durch Streptokokken verursachte, schwere Weichteilinfektion, bei der eine antimikrobielle Therapie indiziert ist. In der Literatur sind viele verschiedene Therapieschemata beschrieben, die \u00fcberwiegend auf empirischen Daten basieren und nur teilweise durch Studien belegt sind.<\/jats:p><jats:p><jats:italic>Material und Methoden:<\/jats:italic>Ziel der vorgestellten Erhebung war es, mittels eines Fragebogens, die Erysipelbehandlung in Deutschland und \u00d6sterreich abzubilden und hieraus Therapieempfehlungen abzuleiten.<\/jats:p><jats:p><jats:italic>Ergebnisse und Schlu\u00dffolgerung:<\/jats:italic>In den befragten Kliniken wird das Erysipel pr\u00e4ferentiell intraven\u00f6s unter station\u00e4ren Bedingungen behandelt. Am h\u00e4ufigsten wird in der \u201efirst line\u201d\u2010Therapie Penicillin G (80\u2003%) eingesetzt. Daneben werden Aminopenicilline (11\u2003%), Cephalosporine (16,5\u2003%) und Isoxazolylpenicilline (6,9\u2003%) eingesetzt. Als \u201esecond line\u201d\u2010Therapie werden haupts\u00e4chlich Makrolide (63,5\u2003%), Clindamycin (52,5\u2003%), Penicilline (18,5\u2003%), Cephalosporine (40\u2003%) und Gyrasehemmer (20,5\u2003%) sowie seltener Carbapeneme, Tetrazykline, Nitroimidazole, Glykopeptitantibiotika, Aminoglykoside, Cotrimoxazol, Fusidins\u00e4ure und Fosfomycin angewendet. Die Therapiedauer betr\u00e4gt im Durchschnitt 10 Tage. Als adjuvante Ma\u00dfnahmen kommen eine Antikoagulation, nichtsteroidale Antiphlogistika, Lokaltherapien, Ruhigstellung und eine Sanierung der Eintrittspforte zum Einsatz.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2005.04799.x","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T17:34:50Z","timestamp":1110562490000},"page":"263-270","source":"Crossref","is-referenced-by-count":5,"title":["Therapie des Erysipels in Deutschland und \u00d6sterreich \u2013 Ergebnisse einer Umfrage an deutschen und \u00f6sterreichischen Hautkliniken"],"prefix":"10.1111","volume":"3","author":[{"given":"Sabine","family":"Brennecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Sch\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Rasokat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Tschachler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,3,16]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"22","article-title":"Harmlos oder gef\u00e4hrlich? So sch\u00e4tzen Sie Weichteilinfektionen richtig ein","volume":"15","author":"Sendt W","year":"2001","journal-title":"MMW"},{"key":"e_1_2_5_3_2","first-page":"97","article-title":"Dermo\u2010hypodermal bacterial infections. Current concepts","volume":"1","author":"Bernhard P","year":"1992","journal-title":"Advances in Medical Science"},{"key":"e_1_2_5_4_2","first-page":"119","article-title":"Common bacterial skin infections","volume":"66","author":"Stulberg DL","year":"2002","journal-title":"Am Fam Phys"},{"key":"e_1_2_5_5_2","first-page":"459","article-title":"Bacterial infections of the skin","volume":"27","author":"Rhody C","year":"2000","journal-title":"Dermatology"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb04833.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200219050-00002"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01646044"},{"key":"e_1_2_5_9_2","unstructured":"AltmeyerP Bacharach\u2010BuhlesM. Dermatologie Allergologie Umweltmedizin 1. Auflage Springer Verlag Berlin 2002 pp. 476\u200a\u2013\u200a479."},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-4362.1985.tb05750.x","article-title":"Erysipelas","volume":"24","author":"Chartier C","year":"1985","journal-title":"Int J Dermatol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archderm.1989.01670180051004","article-title":"Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using direct immunofluorescence technique","volume":"125","author":"Bernard P","year":"1989","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1996.tb02971.x"},{"key":"e_1_2_5_13_2","unstructured":"Braun\u2010FalcoO PlewigG WolffHH. Dermatologie und Venerologie 4. Auflage Springer Verlag Berlin 1995 pp. 199\u200a\u2013\u200a202."},{"key":"e_1_2_5_14_2","first-page":"429","article-title":"Erysipele: quelle prise en charge?","volume":"128","author":"Granier L","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_15_2","first-page":"463","article-title":"Societe Francaise de Dermatologie. Erysipele et fasciite necrosante: prise en charge. Text long","volume":"128","author":"Conference de Consensus","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_16_2","first-page":"338","article-title":"Prise en charge des dermo\u2010hypodermites bacteriennes par les medicins generalistes: enquete de practique et etude prospective","volume":"28","author":"Kopp M","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_17_2","first-page":"2424","article-title":"Skin and wound infections: An overview","volume":"57","author":"O'Dell ML","year":"1998","journal-title":"Am Fam Phys"},{"key":"e_1_2_5_18_2","first-page":"363","article-title":"Criteres d'hospitalisation initiale et secondaire","volume":"128","author":"Bernhard P","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_19_2","first-page":"334","article-title":"A prospective study on erysipelas and infectious cellulitis: How are they dealt within hospital? Review","volume":"128","author":"Schmit JL","year":"2001","journal-title":"Annal Dermatol Venereol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1996.tb138641.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00325481.1993.11701692","article-title":"Common bacterial skin infections. Diagnostic and therapeutic clues","volume":"93","author":"Kahn RM","year":"1993","journal-title":"Postgraduate Medicine"},{"key":"e_1_2_5_22_2","first-page":"1171","article-title":"Erysipele","volume":"114","author":"Cremieux A\u2010C","year":"1987","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_23_2","first-page":"345","article-title":"Quelle prise en charge pour l'erysipele? Traitement antibiotique: molecules, voies d'administration","volume":"128","author":"Lucht F","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_24_2","unstructured":"OrfanosCE GarbeC. Therapie der Hautkrankheiten 2. Auflage Springer Verlag Berlin 2002 pp. 12\u200a\u2013\u200a14."},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-4362.1985.tb05415.x","article-title":"Erysipelas. Changing faces","volume":"24","author":"Ronnen M","year":"1985","journal-title":"Int J Dermatol"},{"key":"e_1_2_5_26_2","first-page":"585","article-title":"Erysipele. Donnees recentes et questions d'actualite","volume":"123","author":"Petit A","year":"1996","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2000.tb10932.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91835-5"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2005.04799.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2005.04799.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T01:27:53Z","timestamp":1706059673000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2005.04799.x"}},"subtitle":["Treatment of erysipelas in Germany and Austria \u2013 Results of a survey in German and Austrian dermatological clinics"],"short-title":[],"issued":{"date-parts":[[2005,3,16]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.1610-0387.2005.04799.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2005.04799.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,16]]}}}